A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

NCT06148636 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumors
Neuroendocrine Tumor of the Lung
Neuroendocrine Tumor Grade 1
Neuroendocrine Tumor Grade 2
Neuroendocrine Tumor of Pancreas

Interventions

DRUG: [212Pb] VMT-α-NET
DIAGNOSTIC_TEST: [203Pb] VMT-α-NET SPECT/CT

Sponsor

David Bushnell

Collaborators

[object Object]
[object Object]
[object Object]